Modeling and antitumor studies of a modified L–penetratin peptide targeting E2F in lung cancer and prostate cancer

E2F1-3a overexpression due to amplification or to mutation or loss of the retinoblastoma gene, induces genes involved in DNA synthesis and leads to abnormal cellular proliferation, tumor growth, and invasion. Therefore, inhibiting the overexpression of one or more of these activating E2Fs is a recog...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Shaik, Tazeem, Rather, Gulam M., Bansal, Nitu, Minko, Tamara, Garbuzenko, Olga, Szekely, Zoltan, Abali, Emine E., Banerjee, Debabrata, Kerrigan, John E., Scotto, Kathleen W., Bertino, Joseph R.
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2018
Sujets:
Priority Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6161789/
https://ncbi.nlm.nih.gov/pubmed/30279956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26064
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires